Entrada Therapeutics Ownership | Who Owns Entrada Therapeutics?
Entrada Therapeutics Ownership Summary
Entrada Therapeutics is owned by 88.57% institutional investors, 12.83% insiders. Baker bros. advisors lp is the largest institutional shareholder, holding 14.53% of TRDA shares. T. Rowe Price New Horizons is the top mutual fund, with 5.22% of its assets in Entrada Therapeutics shares.
TRDA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Entrada Therapeutics | 88.57% | 12.83% | -1.41% |
| Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
| Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Baker bros. advisors lp | 4.87M | 14.53% | $69.34M |
| Mpm asset management | 4.43M | 13.21% | $63.07M |
| 5am venture management | 4.41M | 13.16% | $62.82M |
| Price t rowe associates inc /md/ | 3.13M | 9.36% | $44.67M |
| Fmr | 1.83M | 5.46% | $26.07M |
| Blackrock | 1.69M | 5.06% | $24.14M |
| Janus henderson group | 1.55M | 4.63% | $22.11M |
| Vanguard group | 1.13M | 3.37% | $16.10M |
| Wellington management group llp | 1.03M | 3.09% | $14.73M |
| Stepstone group lp | 761.28K | 2.27% | $10.85M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Mpm asset management | 4.43M | 34.64% | $63.07M |
| 5am venture management | 4.41M | 14.05% | $62.82M |
| Stepstone group lp | 761.28K | 2.20% | $10.85M |
| Baker bros. advisors lp | 4.87M | 0.89% | $69.34M |
| Tcg crossover management | 584.96K | 0.87% | $8.34M |
| Nan fung group | 49.08K | 0.75% | $699.42K |
| Corton capital | 54.97K | 0.41% | $783.37K |
| Moore capital management, lp | 105.00K | 0.03% | $1.50M |
| Gsa capital partners llp | 21.29K | 0.02% | $303.00K |
| Pdt partners | 12.54K | 0.02% | $178.67K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 1.83M | 0.00% | 1.66M |
| Janus henderson group | 1.55M | 0.01% | 1.55M |
| Price t rowe associates inc /md/ | 3.13M | 0.01% | 381.10K |
| Blackrock | 1.69M | 0.00% | 207.70K |
| Jacobs levy equity management | 134.24K | 0.01% | 134.24K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Redmile group | - | - | -560.97K |
| Schonfeld strategic advisors | - | - | -81.41K |
| Morgan stanley | 49.05K | 0.00% | -58.51K |
| Citigroup | 5.54K | 0.00% | -50.74K |
| Winton group | - | - | -32.55K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Janus henderson group | 1.55M | 0.01% | 1.55M | $22.11M |
| Jacobs levy equity management | 134.24K | 0.01% | 134.24K | $1.91M |
| Renaissance | 44.60K | 0.00% | 44.60K | $635.55K |
| Jane street group | 26.75K | 0.00% | 26.75K | $381.25K |
| Gsa capital partners llp | 21.29K | 0.02% | 21.29K | $303.00K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -4.00 |
| Advantage alpha capital partners lp | -20.00 |
| Plato investment management | -61.00 |
| Metropolitan life insurance co/ny | -1.21K |
| New york state teachers retirement system | -1.92K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 82 | 7.89% | 29,668,719 | 13.99% | 88 | 1.43% | 58 | 61.11% | 11 | -52.17% |
| Mar 31, 2024 | 76 | 22.58% | 26,027,444 | -0.97% | 78 | 1.26% | 36 | 12.50% | 23 | 64.29% |
| Dec 31, 2023 | 62 | 12.73% | 26,281,950 | 0.95% | 78 | 1.28% | 32 | 39.13% | 14 | - |
| Sep 30, 2023 | 55 | -1.79% | 26,035,608 | 1.10% | 78 | 1.24% | 23 | -32.35% | 14 | 27.27% |
| Jun 30, 2023 | 56 | 5.66% | 25,751,810 | 3.42% | 79 | 1.34% | 34 | - | 11 | 83.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| T. Rowe Price New Horizons | 1.94M | 5.22% | -76.04K |
| US Small-Cap Growth II Equity Comp | 1.94M | 5.22% | -76.85K |
| Vanguard Total Stock Mkt Idx Inv | 686.72K | 1.84% | 9.31K |
| iShares Russell 2000 ETF | 634.83K | 1.70% | -1.43K |
| Fidelity Select Biotechnology | 600.37K | 1.61% | 30.50K |
| Fidelity Growth Compy Commingled Pl S | 564.26K | 1.52% | 3.08K |
| Fidelity Growth Compy Commingled Pl O | 561.18K | 1.51% | - |
| T. Rowe Price New Horizons Tr-Z | 449.11K | 1.21% | 58.56K |
| Fidelity Growth Company Fund | 357.80K | 0.96% | -760.00 |
| Vanguard Institutional Extnd Mkt Idx Tr | 292.65K | 0.79% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 11, 2024 | Sethuraman Natarajan | President, Research & Develop. | Sell | $28.19K |
| Nov 13, 2024 | Sethuraman Natarajan | President, Research & Develop. | Sell | $54.11K |
| Nov 11, 2024 | WENTWORTH KORY JAMES | Chief Financial Officer | Sell | $172.56K |
| Nov 04, 2024 | Sethuraman Natarajan | President, Research & Develop. | Sell | $13.50K |
| Nov 05, 2024 | Sethuraman Natarajan | President, Research & Develop. | Sell | $94.01K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 8 |
| 2024 Q3 | - | 13 |
| 2024 Q2 | 6 | 6 |
| 2024 Q1 | 7 | 4 |
| 2023 Q4 | - | 7 |
TRDA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools